Related Experiment Video
Updated: Jan 9, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Topiramate-Induced Bilateral Acute Angle Closure in a Healthy Young Female
Michael J Miyashiro1, William A Newsom2, Nikki P Inamine3
1Ophthalmology, Eyeball Doc LLC, Bradenton, USA.
Topiramate is a widely prescribed medication for epilepsy, migraine prophylaxis, and weight management, but it can rarely cause acute bilateral angle closure with myopic shift. We describe a healthy 35-year-old woman who developed sudden bilateral painful red eyes, blurred vision, and a myopic shift within one week of initiating topiramate. Examination revealed shallow anterior chambers, elevated intraocular pressure, and iridocorneal touch bilaterally. Prompt discontinuation of topiramate led to full resolution. Laser peripheral iridotomies (LPIs) were performed while the etiology was uncertain, and are not typically required in medication-induced effusion-related angle closure. This case underscores that cycloplegia and drug cessation are the key interventions, while LPI may be performed only when the underlying mechanism is unclear. This case highlights the importance of recognizing medication-induced angle closure and distinguishing it from primary pupillary-block mechanisms to ensure timely, vision-saving management.
Topiramate is a widely prescribed medication for epilepsy, migraine prophylaxis, and weight management, but it can rarely cause acute bilateral angle closure with myopic shift. We describe a healthy 35-year-old woman who developed sudden bilateral painful red eyes, blurred vision, and a myopic shift within one week of initiating topiramate. Examination revealed shallow anterior chambers, elevated intraocular pressure, and iridocorneal touch bilaterally. Prompt discontinuation of topiramate led to full resolution. Laser peripheral iridotomies (LPIs) were performed while the etiology was uncertain, and are not typically required in medication-induced effusion-related angle closure. This case underscores that cycloplegia and drug cessation are the key interventions, while LPI may be performed only when the underlying mechanism is unclear. This case highlights the importance of recognizing medication-induced angle closure and distinguishing it from primary pupillary-block mechanisms to ensure timely, vision-saving management.
Related Concept Videos
Angle Closure Glaucoma: Treatment
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Glaucoma: Overview

